NCT04994457Completed
Patient Performance on Virtual Reality Visual Field Devices as Compared to Standard of Care
Source: ClinicalTrials.gov · Last updated 27 Jun 2024
Brief summary (registry, in English)
The purpose of this research is to study the effectiveness and patient experience when measuring visual fields using virtual reality goggles.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 287 (actual)
- First submitted
- 29 Jul 2021
- Start date
- 30 Oct 2021
- Primary completion date
- 21 Jun 2024
- Lead sponsor
- University of Miami
- Diseases
- Glaucoma
- NCT number
- NCT04994457
What you commit to
- Study type: Observational
- Participants enrolled: 287
- From 30 Oct 2021 to the primary completion date, 21 Jun 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- Inclusion:
- Any individual who is physically able to take a virtual reality visual field test
- Patients who either have glaucoma, are glaucoma suspects, or have a strong family history of glaucoma, or have other visual field defects, and normal individual
- Age: Individuals who are old enough to comprehend the instructions and procedures (1-90)
- Exclusion:
- Adults unable to consent, prisoners
- Participants who are too tired to take a visual field test
- Participants who refuse to consent
- Individuals who are functionally unable to use VRVF
Age in the registry: 1 year to 90 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bascom Palmer Eye Institute Coordinator of this site? Confirm its status | Miami | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.